Standout Papers

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer... 2004 2026 2011 2018 1.4k
  1. Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 (2004)
    Roy S. Herbst, Giuseppe Giaccone et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 30 from Science/Nature 98 standout
Sub-graph 1 of 16

Citing Papers

Fibrosis: from mechanisms to medicines
2020 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
2 intermediate papers

Works of Ira A. Oliff being referenced

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer
2015
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer
2008

Author Peers

Author Last Decade Papers Cites
Ira A. Oliff 1256 443 53 1189 12 1.7k
Xiuyu Julie Cong 1211 555 30 1270 19 1.7k
H. Spiridonidis 1640 531 28 1730 6 2.1k
Jaromı́r Roubec 1250 568 47 1249 19 1.6k
G Pomatico 973 584 34 616 8 1.4k
J.R. Woodburn 940 688 50 607 14 1.7k
Shailaja Kalyankrishna 700 687 56 575 9 1.3k
L. Fehrenbacher 1398 347 24 1337 32 1.7k
Nadia Godin-Heymann 1047 942 31 1066 10 1.7k
Daniel Haggstrom 1172 681 37 1435 22 1.8k
Xin Li 1121 371 56 1168 38 1.5k

All Works

Loading papers...

Rankless by CCL
2026